Insider Holders & Insider Ownership - AbbVie Inc. (ABBV)

List of insiders holdings for AbbVie Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
GONZALEZ RICHARD A
CHAIRMAN OF THE BOARD AND CEO
2024-03-01 17:50:08519,099
0
519,099Form 4
Schumacher Laura J
Vice Chairman
2022-03-01 18:06:47248,002
0
248,002Form 4
SEVERINO MICHAEL
Vice Chairman
2022-05-25 16:58:03233,769
0
233,769Form 4
SALEKI-GERHARDT AZITA
EVP, CHIEF OPERATIONS OFFICER
2024-03-01 17:50:27219,978
6195
226,173Form 4
CHASE WILLIAM J
EVP, Finance & Administration
2019-06-28 16:47:58169,552
501
170,053Form 4
LEONARD JOHN M.
SVP, Chief Scientific Officer
2013-03-19 17:13:47154,020
6473
160,493Form 4
ALBAN CARLOS
Vice Chairman
2020-11-18 17:04:53114,899
40,442
155,341Form 4
FREYMAN THOMAS C
Director
2023-05-09 17:00:19124,226
7882
132,108Form 4
Hudson Thomas J
SVP, CSO, GLOBAL RESEARCH
2024-03-01 17:50:17107,267
0
107,267Form 4
Gosebruch Henry O
EVP, Chief Strategy Officer
2022-05-20 17:03:5641,623
57,138
98,761Form 4/A
Michael Robert A.
PRES & CHIEF OPERATING OFFICER
2024-03-01 17:50:4298,645
0
98,645Form 4
HURWICH THOMAS A.
VP, Controller
2017-03-02 18:12:4662,329
721
63,050Form 4
Stewart Jeffrey Ryan
EVP, CHIEF COMMERCIAL OFFICER
2024-03-20 17:00:1160,941
1338
62,279Form 4
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
2024-03-22 17:00:1555,903
0
55,903Form 4
TILTON GLENN F
Director
2023-05-09 17:05:1949,039
350
49,389Form 4
Sorg Elaine K.
SVP, US COMMERCIAL OPERATIONS
2023-04-27 17:00:1847,588
0
47,588Form 4
AUSTIN ROXANNE S
Director
2023-05-09 17:02:0935,933
0
35,933Form 4
Durkin Brian L
VP, CONTROLLER
2023-03-02 17:03:4333,149
0
33,149Form 4
Reents Scott T
EVP, CHIEF FINANCIAL OFFICER
2024-03-01 17:50:4932,811
0
32,811Form 4
LIDDY EDWARD M
Director
2022-04-04 17:16:2528,474
0
28,474Form 4
Strom Carrie C
SVP & PRES GLOBAL ALLERG AESTH
2023-05-12 17:00:1428,024
0
28,024Form 4
ROBERTS ROY S
Director
2015-05-12 17:53:2327,486
0
27,486Form 4
WADDELL FREDERICK H
Director
2023-05-09 17:05:2026,433
0
26,433Form 4
RAPP EDWARD J
Director
2024-04-02 17:00:1225,701
0
25,701Form 4
BURNSIDE WILLIAM H.L.
Director
2023-05-09 17:00:2424,433
0
24,433Form 4
Thakkar Roopal
SVP, CMO, GLOBAL THERAPEUTICS
2024-03-01 17:50:1123,259
0
23,259Form 4
Hart Brett J
Director
2023-05-09 17:02:3916,947
0
16,947Form 4
MEYER MELODY B
Director
2023-05-09 17:03:3613,973
0
13,973Form 4
RICHMOND TIMOTHY J.
EVP, CHIEF HR OFFICER
2024-03-05 17:30:5013,837
0
13,837Form 4
Roberts Rebecca B
Director
2023-05-09 17:04:4811,203
0
11,203Form 4
Siatis Perry C
EVP, GC AND SECRETARY
2024-03-01 17:50:3810,397
0
10,397Form 4
Alpern Robert J
Director
2024-04-02 17:00:339408
0
9408Form 4
Buckbee Kevin K
SVP, CONTROLLER
2024-03-01 17:50:456983
0
6983Form 4
Quaggin Susan E
Director
2024-04-02 17:00:37147
0
147Form 4
ABBOTT LABORATORIES
10% Owner
2012-12-14 17:22:44101
0
101Form 4
Davis Jennifer L.
Director
2023-10-19 17:06:080
0
0Form 3
LINDER GREG W
Director
2012-12-07 18:48:280
0
0Form 3